EDIT vs ITW · rev $32.3M vs P/E 22, rev $16.04B
Editas Medicine Inc (EDIT) versus Illinois Tool Works Inc (ITW) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Illinois Tool Works Inc (ITW) is a specialty industrial machinery company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported ITW revenue for 2025-12-31 was $16.04B. Net income was $3.07B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
EDIT currently screens at market cap $375.2M. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
Not investment advice. Open the EDIT and ITW stock pages for the full models.
Not investment advice.